[ad_1] The badessment of the potential impact on patients of impurity that led to the withdrawal of many lots of valsartan-based drugs throughout Europe in the first week of July "is a …
Read More »Ema on the removal of Valsartan: the revision of the taxation is in progress. The contaminant would be present from 2012
